近日，陆道培医院陆佩华院长作为第一作者和通讯作者，在国际血液学权威期刊 Blood（IF = 21）在线发表了题为「Nanobody-based Naturally Selected CD7-Targeted Chimeric Antigen ...

Acute myeloid leukemia (AML) refers to a heterogeneous group of hematopoietic malignancies. The well-known European Leukemia Network (ELN) stratifies AML patients into three risk groups, based ...

Along with GC012F, Gracell’s pipeline includes a dual-targeting CAR-T for acute myelogenous leukaemia (AML), a CD19/CD7 therapy for B-cell acute lymphoblastic leukaemia (B-ALL), and BCMA/CD7 ...

骨髓是人体造血的“工厂”，而骨髓增生异常肿瘤（MDS）则是这座工厂的“生产线故障”——血细胞发育异常，导致贫血、感染甚至白血病风险升高。 过去，MDS诊断高度依赖骨髓涂片的形态学观察，但仅凭细胞形态差异（如“病态造血”），难以区分MDS与其他良性血液病（如再生障碍性贫血）。2008年，欧洲白血病网络（ELN）首次将流式细胞术纳入MDS诊断体系，提出通过检测细胞表面抗原的异常表达模式（如CD34+祖 ...

7, 2024 — Fratricide-resistant CD7 CAR-T therapy by NUS proves effective ... uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the ...

Despite stringent anti-money laundering (AML) laws implemented by regulatory bodies, compliance remains a significant hurdle for financial institutions. One industry leader addressing these challenges ...

Natural killer (NK) cells are the predominant innate lymphocyte subsets that mediate anti-tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells do not express ...